U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06928649) titled 'Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies' on March 24.
Brief Summary: In order to better determine which therapy is best for patients which present with organ falure during the course of their stay in the intesive care unit (ICU) , one has to determine which underlying mechanism is causing this organ falure. We will determine levels of so called "biomarkers" for ferroptosis (a mechan ism of iron-related cell death) in the peripheral blood and biological fluids of criticaly ill patients admitted to the ICU with a catastrrophy (severe infection, trauma ...) . Why ? If it turns ou...